Crossmark

Loss of CD44 and SOX2 Expression is Correlated with a Poor Prognosis in Esophageal Adenocarcinoma Patients

Crossref DOI link: https://doi.org/10.1245/s10434-014-3763-x

Published Online: 2014-05-16

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Honing, Judith

Pavlov, Kirill V.

Meijer, Coby

Smit, Justin K.

Boersma-van Ek, Wytske

Karrenbeld, Arend

Burgerhof, Johannes G. M.

Kruyt, Frank A. E.

Plukker, John Th. M.
License Information

Text and Data Mining valid from 2014-05-16